<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Catabasis Pharmaceuticals e Sarepta Therapeutics Annunciano una Collaborazione di Ricerca Congiunta nella Distrofia Muscolare di Duchenne	</title>
	<atom:link href="https://www.parentproject.it/2016/10/01/catabasis-pharmaceuticals-e-sarepta-therapeutics-annunciano-una-collaborazione-di-ricerca-congiunta-nella-distrofia-muscolare-di-duchenne/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.parentproject.it/2016/10/01/catabasis-pharmaceuticals-e-sarepta-therapeutics-annunciano-una-collaborazione-di-ricerca-congiunta-nella-distrofia-muscolare-di-duchenne/</link>
	<description>Insieme per fermare la Duchenne e la Becker</description>
	<lastBuildDate>Fri, 30 Sep 2016 23:03:36 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
